Standards for PBSC mobilisation and collection

Annals of Oncology

Volumn 7, Issue SUPPL. 2, 1996, Pages 9-10

  Linch, D C ^a,b   Watts, M J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Peripheral blood stem cells; Progenitor assays; Progenitor thresholds; Review; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT;

BLOOD SAMPLING; CELL COUNT; DOSE RESPONSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; MULTIMODALITY CANCER THERAPY; REVIEW; STANDARD;

ANTINEOPLASTIC AGENTS; BLOOD SPECIMEN COLLECTION; CELL COUNT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA;

EID: 2342650943     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_2.9     Document Type: Review

References (11)

1. Jones RJ, Wagner JE, Celano P et al. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 1990; 347: 188-9.
2. Kaizer H, Stuart RK, Brookmeyer R et al. Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 1985; 65: 1504-10.
3. Robertson MJ, Soiffer RJ, Freedman AS et al. Human bone marrow depleted of CD33 positive cells mediates delayed but durable reconstitution of hemopoiesis: Clinical trial of MY9 monoclonal antibody purged autografts for the treatment of acute myeloid leukaemia. Blood 1992; 79: 2229-36.
4. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1989; 74: 1905-14.
5. + cells. In Wunder E, Sovalat H, Hénon P et al. (eds): Hematopoietic Stem Cells: The Mulhouse Manual. Dayton: AlphaMed Press 1994; 61-6.
6. Jones HM, Jones SA, Watts MJ et al. Development of a simplified single apheresis approach for PBSC transplantation in previously treated patients with lymphoma. J Clin Oncol 1994; 12: 1693-702.
7. 2 and G-CSF. Blood 1995; 86 (Suppl 1): 1621 (Abstr).
8. Haas R, Mohle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-94.
9. Schneider JG, Crown JP, Wasserheit C et al. Factors influencing the mobilisation of primitive and committed haematopoietic progenitors into the peripheral blood of cancer patient. Bone Marrow Transplant 1994; 14: 877-84.
10. Demirer T, Besinger WI. Optimisation of peripheral blood stem cell collection. Curr Opin Haematol 1995; 2: 219-26.
11. Haas R, Witt B, Mohle R et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995; 85: 3754-61.